Key takeaways:
Telehealth on the rise
Telehealth, a case of technology meeting healthcare, has become trendy in recent years.
In Hong Kong, hospitals, clinics and telecommunications companies have been increasingly shifting medical services to patients’ homes2. Since the start of the global public health crisis, 95% of physicians have increased their use of video consultations by 50% to provide medical care to patients3, reducing patients’ and clinicians’ risk of exposure and infection.
Remote patient monitoring and self-diagnostics, and trials of hybrid online-and-offline models are bringing new care models for patients amid accelerating investments in digital health, according to a McKinsey & Co. report4. The total venture capital investment into the digital health space stood at US$14.7 billion in 1H 2021, compared with investment of US$14.6 billion for the whole of 2020, and nearly twice the investment of US$7.7 billion in 20194.
Additionally, structure trends of an ageing population, exponential increase in expenditure and the need for better efficiencies in the healthcare system are presenting long-term investment growth opportunities for the medtech industry1.
Adding a robotics touch
Medical organisations are increasingly harnessing smart technologies to accelerate efficiencies, reduce unnecessary treatments and improve preventive care.
For example, some medtech companies have been applying machine learning and artificial intelligence (AI) technologies when designing and upgrading surgical robots, allowing for greater precision during surgical operations. This has resulted in shorter patient recovery time. In addition to AI innovation in diagnostics and surgery, advanced technologies in healthcare also provide investment exposure to medical devices.
Taking more steps a day
Additionally, supportive government initiatives such as using big data in smart healthcare - storing the residents’ lifelong health records in an encrypted format shared by private and public hospitals5 – could improve the healthcare service quality and have given the medtech industry a boost.
Smart technologies have also started to integrate in the way people live. The Singapore government has a physical activity programme, the “National Steps Challenge” to promote healthy living. With step-trackers, residents are encouraged to walk more than 10,000 steps a day. Since its launch in November 2015, 70% of previously inactive participants have now averaged more than 7,000 steps per day, with 30% of participants clocking about 10,000 steps a day on average6.
Taking more steps a day
Additionally, supportive government initiatives such as using big data in smart healthcare - storing the residents’ lifelong health records in an encrypted format shared by private and public hospitals5 – could improve the healthcare service quality and have given the medtech industry a boost.
Smart technologies have also started to integrate in the way people live. The Singapore government has a physical activity programme, the “National Steps Challenge” to promote healthy living. With step-trackers, residents are encouraged to walk more than 10,000 steps a day. Since its launch in November 2015, 70% of previously inactive participants have now averaged more than 7,000 steps per day, with 30% of participants clocking about 10,000 steps a day on average6.
Conclusion
The demand for telehealth, innovative AI technologies and medical devices is accelerating after the global public health crisis4. This rising demand is also driven by structural trends such as an increasingly ageing population in many major economies. Governments are also increasingly adopting innovative technologies to improve healthcare efficiencies and quality. Innovating medtech companies are thus presenting investors with exposure to long-term growth opportunities1 in the industry.
This content represents our investment team’s current view and overall strategy provided for information only based on current market conditions not taking into consideration any specific investor’s investment objective and risk appetite. Not to be construed as investment recommendation or advice.
Diversification does not guarantee investment return and does not eliminate the risk of loss.
1. For illustrative purposes only based on current market conditions, subject to change from time to time. Not all investments are suitable for all investors. Exact allocation of portfolio depends on each individual’s circumstance and market conditions.
2. Source: “Why telehealth?”, Smart Nation Singapore, updated as of 31.08.2021.
3. Source: “Pulse of the industry: medical technology report 2020”, Ernst and Young , Fall 2020. Provided for information only to illustrate macro trends not to be construed as offer, research or investment advice.
4. Source: “Telehealth: A quarter-trillion-dollar post COVID-19 reality?”, McKinsey & Company, 09.07.2021.
5. Source: “Hong Kong Smart City Blueprint 2.0”, Innovation and Technology Bureau, Hong Kong, December 2020.
6. Source: “National Steps Challenge & the Healthy 365 app”, Smart Nation Singapore, updated as of 30.08.2021.
This advertisement or publication has not been reviewed by the Monetary Authority of Singapore. It does not constitute investment advice, or an offer to sell, or a solicitation of an offer to buy any security, investment product or service. Informational sources are considered reliable but you should conduct your own verification of information contained herein. Investment involves risk. Investments in funds are not deposits and are not considered as being comparable to deposits. Past performance is not indicative of future performance and investors may not get back the full or any part of the amount invested. Dividend distributions if any are not guaranteed and are made at the manager’s discretion. Fund’s net asset value may likely have high volatility due to its investment policies or portfolio management techniques. The value of the units in the scheme and the income accruing to the units, if any, may fall or rise. Funds which are invested in emerging markets, smaller companies and financial derivative instruments may also involve higher risks and are usually more sensitive to price movements. Any applicable currency hedging process may not give a precise hedge and there is no guarantee that any hedging will be successful. Investors in a currency hedged fund or share class may have exposure to currencies other than the currency of their fund or share class. Investors should make their own investigation or evaluation or seek independent advice prior to making any investment. Please refer to the Singapore Offering Documents (including the risk factors set out therein) and the relevant Product Highlights Sheet for details at https://am.jpmorgan.com/sg/en/asset-management/per/. To the extent permitted by applicable law, we may record telephone calls and monitor electronic communications to comply with our legal and regulatory obligations and internal policies. Personal data will be collected, stored and processed by J.P. Morgan Asset Management in accordance with https://am.jpmorgan.com/sg/en/asset-management/per/privacy-statement/. Issued by JPMorgan Asset Management (Singapore) Limited (Co. Reg. No. 197601586K). All rights reserved.
For Fund or Institutional enquiries, please call or email us. You can also contact your financial advisor or your J.P.Morgan Representative.